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Abstract
Background: Patients with acute coronary syndromes (ACS) are at increased risk of further acute cardiac
events. Secondary prevention aims to decrease morbidity and mortality post-ACS. Depression is related to
increased risk in this population, and to poorer secondary prevention activities. However, lengthy depression
assessment techniques preclude depression assessment in routine care. The present study investigated the
relationship of briefly-assessed depression with secondary prevention outcomes one year post-ACS.
Methods: Following ethics committee approval, hospitals recruited patients for a national survey of ACS.
Consenting patients with ACS completed a brief depression scale during hospitalisation. The predictive validity of
two brief scales was independently assessed, with groups combined for the overall sample. Participants then
completed a one-year longitudinal follow-up postal survey of secondary prevention activities.
Results: The response rate for follow-up was 86% (n = 681). Proportions taking anti-platelet (88% v 87%; p =
0.334) and lipid-lowering (83% v 84%; p = 0.437) therapies remained unchanged. Prevalence of smoking (40% v
22%; p < 0.001), and median number of cigarettes smoked (20 v 10; p < 0.001) were significantly reduced at one
year. Fifty-six per cent of patients reported attending cardiac rehabilitation programmes. Of those aged <65 years
at baseline, 54% had returned to work at one year. A majority (56%) reported feeling physically better. Prevalence
of depression was unchanged in those who completed a depression scale at both time points (15% v 17%; p =
0.434). Baseline depression did not predict taking anti-platelet, blood pressure or cholesterol medications (all p
> 0.05), but did predict continuation of smoking (OR = 2.3, 95% CI 1.3–4.0, p = 0.003), a higher (above median)
number of general practitioner visits (OR = 2.1, 95% CI 1.3–3.4, p = 0.005), failure to return to work (OR = 0.4,
95% CI 0.2–0.8, p = 0.015), and not feeling better (OR = 0.6, 95% CI 0.3–1.0, p = 0.05) at one year.
Conclusion: Rapid depression assessment can be used to help identify patients with ACS at risk of a range of
poorer secondary prevention outcomes. The results provide support for the routine screening of depression in
acute settings. Strategies to increase rates of smoking cessation, return to work, general well-being and decrease
health service use by depressed patients may need to incorporate some element of treatment for depression.
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Background
Patients with acute coronary syndrome (ACS; unstable
angina or myocardial infarction) are at increased risk of
cardiovascular morbidity and mortality, and therefore sec-
ondary prevention is an important consideration for
health providers [1-3]. Reductions in subsequent morbid-
ity and mortality have been established through the use of
anti-platelet, anti-hypertensive and lipid-lowering medi-
cations; participation in exercise, dietary and cardiac reha-
bilitation programmes; and through smoking cessation
[1-3]. However, there is ample evidence that recom-
mended secondary prevention targets are not currently
being met [4-7]. Furthermore, patient benefit may be less
than assured since patient adherence to prescribed medi-
cations may be substantially poorer than prescription
rates recorded in medical records [8,9]. Therefore it is
important to monitor the current self-reported secondary
prevention behaviours of patients with ACS.
Patients with ACS who also have depression are at greater
risk of further cardiovascular events than those without
depression [10-12]. One reason for this may be that
depressed patients have poorer secondary prevention pro-
files [13]. Depression is known to predict outcomes in
patients with ACS, including mortality, health service use
and secondary prevention activities such as smoking ces-
sation and medication adherence [10-15]. Depression is
also related to other psychosocial outcomes such as
returning to work after cardiovascular disease, and is asso-
ciated with failing to increase leisure exercise [16-19]. The
prevalence of depression remains steady for up to 5 years
following hospitalisation for ACS [20]. Depressed
patients rate their quality of life as being lower after car-
diac illness [21]. Although the treatment of depression
post-ACS has not been shown to reduce morbidity and
mortality, it does improve quality of life [22]. Therefore,
the identification of depression in ACS patients is a signif-
icant concern for the health services, as it increases burden
for services, and negatively affects health outcomes and
quality of life.
It is important to profile surviving patients for effective
planning and evaluation of ongoing care. The continuing
prevalence of depressive symptoms in this population is
unknown, and knowledge of any possible consequence of
depression for secondary prevention outcomes is essential
for health professionals. Most research has used clinical
interviews or lengthy self-completion questionnaires to
assess depression while patients are still in coronary care
settings [10,11,22]. These complex methods mitigate
against routine depression measurement in the majority
of acute settings, and make health services research time-
consuming for both patients and researchers. To become
a standard aspect of coronary care, simple, rapid depres-
sion assessment is required. The present study surveyed a
national cohort of Irish patients one year following hospi-
tal admission for confirmed ACS [23,24], and assessed the
impact of briefly-assessed depression on their secondary
prevention profile. Hospitals were randomly assigned one
of two brief scales – each patient completed only one scale
to minimise research burden in this acute hospital period.
Depressed cases from either scale were combined for anal-
ysis. The results were also analysed for each scale sepa-
rately and the findings compared.
Methods
Participants and procedure
The baseline methodology has been described previously
[23,24]. Briefly, after receiving ethical approval [25], all
Irish centres admitting ACS patients to intensive/coronary
care were invited and agreed to participate in a survey
focusing on time-to-treatment and reperfusion (throm-
bolysis and/or direct infarct angioplasty) for eligible
patients. Consecutive suspected ACS patients were
recruited by staff to participate in the survey, until 25 sus-
pected acute myocardial infarction patients were
recruited. Patients were asked for consent to participate in
a one-year outcomes survey during index hospitalisation,
and were given a depression questionnaire. Surviving
patients (as confirmed by their general practitioner) were
surveyed by post 12 months later. They received a ques-
tionnaire assessing secondary prevention activities, car-
diac rehabilitation, health service use, physical health
rating, return to work, and a repeat depression question-
naire. Non-responders were sent postal reminders after
two and four weeks. Data are presented on confirmed ACS
patients who responded to the postal questionnaire (Fig-
ure 1).
Depression measures
Hospitals were randomly assigned either the 7-item Hos-
pital Anxiety and Depression Scales – depression subscale
Flowchart of patient participation Figure 1
Flowchart of patient participation.BMC Health Services Research 2006, 6:9 http://www.biomedcentral.com/1472-6963/6/9
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(HADS-D) [26] or the 7-item Beck Depression Inventory
– Fast Scale (BDI-FS) [27]. Both scales use a four-answer
option format, and item scores range from 0 to 3, with
higher scores indicating greater symptom severity. In line
with previous research, HADS-D scores >7 [28], and. BDI-
FS scores >3 [27] were defined as indicating depressed
cases. Both scales can be completed within minutes, and
have sensitivity and specificity of >0.80 [27,28]. Patients
scoring above cut-off on whichever scale they completed
were defined as depressed, providing the overall sample of
cases of depression.
Statistical analysis
Analysis was conducted using STATA/SE 8.2, using robust
variance estimation commands to account for original
clustering of patients within hospitals. Median and inter-
quartile range (IQR) are reported for ordinal data, with
changes between baseline and one year tested using the
Wilcoxon matched-pairs signed-ranks test. Logistic regres-
sion predicted odds-ratios (OR) for event occurrence.
Unadjusted ORs are presented, unless stated otherwise.
Age was analysed as a continuous variable with odds
ratios calculated for a 1-year age increase, other variables
were analysed as dichotomous. McNemar's test was used
to compare dichotomous variables between baseline and
one year. Spearman's rank correlation was used to test
relationships between variables which were not normally
distributed. A median split was then utilised in order to
elicit an OR for event occurrence. To compare the depres-
sion scales, dummy variables were created for the total
sample (i.e. scoring above cut-off for HADS-D or not – all
participants who completed a BDI-FS are given a score of
0 in this variable, and vice versa). Both dummy variables
were incorporated into a model, and a post-hoc (Wald)
test then examined whether one scale was superior to the
other as a predictor for event occurrence.
Results
Responders
Of the eligible 791 patients, 681 responded to the survey
questionnaire (86% response rate: 76% men, mean age
63 years, std dev = 12)(see Figure 1). Non-respondents did
not differ to respondents on age, sex, history of hyperten-
sion, smoking, acute coronary syndrome, revascularisa-
tion or total cholesterol level (data not shown, all p >
0.10). However, responders were marginally more likely
to have private health insurance (OR 1.5, 95% CI 0.99–
2.24, p = 0.055), marginally less likely to have diabetes
(OR 0.61, 95% CI 0.37–1.01, p = 0.054), and marginally
less likely to be depressed at baseline (OR 0.56, 95% CI
0.31–1.03, p = 0.064).
Paired comparisons of baseline and one-year 
characteristics
The baseline and one year self-report outcomes are dis-
played in Table 1. At baseline and one year, similar pro-
portions of patients were taking aspirin and lipid-
lowering medications, while significantly fewer reported
taking medication for blood pressure. Both proportion of
smokers, and number of cigarettes smoked, were signifi-
cantly reduced at one year, and the prevalence of depres-
sion had been maintained. The proportions of those aged
<65 years in full-time employment had decreased. Of the
current sample, 36% had a previous history of ACS.
Medications
Baseline depression was not predictive of self-reported use
of aspirin (OR = 0.5, 95% CI 0.3–1.2, p = 0.110), blood
pressure (OR = 0.9, 95% CI 0.5–1.7, p = 0.731) or choles-
terol medications at one year (OR = 0.6, 95% CI 0.3–1.2,
p = 0.164). At one year, proportions of patients taking
medications for depression, anxiety and sleep were 10%,
8% and 15% respectively. Patient reports showed that
Table 1: Profile of cardiovascular medications, smoking and psychosocial status at baseline and one year post-admission
Baseline One year OR 95% CI p-value
Cardiovascular Medications
Aspirin 88% 87% 1.2 0.8–1.8 0.334
Antihypertensive<<>/Blood Pressure 94% 72% 6.8 4.5–10.7 <0.001***
Statins/Cholesterol 83% 84% 0.9 0.6–1.2 0.437
Smoking status
Current Smoker 40% 22% 18.9 9.3–44.5 <0.001***
Median number of cigarettes smoked per day (IQR) 20 (18–30) 10 (7–20) - - <0.001***
Psychosocial status
Full/part-time employment§ 64% 54% 2.7 1.6–4.6 <0.001***
Depression<<><<> 15% 17% 0.8 0.5–1.3 0.434
HADS-D 14% 19% 0.7 0.4–1.2 0.169
BDI-FS 16% 15% 1.3 0.5–2.9 0.701
(*p < .05, **p < .01, ***p < .001)
<<> – includes angiotensin converting enzyme inhibitors, betablockers, calcium antagonists and diuretics
§ – For those patients <65 years on index admission (n = 363)
<<><<> – For those who completed a depression scale at baseline and follow-up (n = 447)BMC Health Services Research 2006, 6:9 http://www.biomedcentral.com/1472-6963/6/9
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those depressed at baseline were more likely to be taking
anti-depressant (OR = 4.1, 95% CI 2.3–7.1, p < 0.001),
anxiolytic (OR = 4.1, 95% CI 1.9–8.9, p = 0.001) or sleep-
ing (OR = 3.2, 95% CI 1.8–5.7, p < 0.001) medications at
one year. Both the baseline and HADS-D and BDI-FS
scales predicted taking these medications at one year (data
not shown, both scales p < 0.01 for each variable).
Health advice, smoking and service use
The majority of patients reported receiving dietary (77%)
and exercise advice (81%), with no influence of baseline
depression (data not shown, p > 0.05).
Patients who were depressed at baseline were no more
likely to be current smokers at index admission (OR = 1.5,
95% CI 0.96–2.3, p = 0.073), but were significantly more
likely to continue to smoke after hospitalisation (OR =
2.3, 95% CI 1.3–4.0, p = 0.003), even when controlling
for a prior history of ACS (OR = 2.4, 95%CI 1.4–4.1, p =
0.003). However, the HADS-D did not predict continua-
tion of smoking at one year (OR = 1.6, 95% CI 0.6–4.3, p
= 0.377), but the BDI-FS did (OR = 2.6, 95% CI 1.4–5.2,
p = 0.007).
Patients reported attending a general practitioner a
median of 5 (IQR 3–10) times in the year following index
admission, with 3% recording no visits to their general
practitioner. Spearman's correlation showed a significant
positive relationship between baseline depression and
number of general practitioner visits (rho = 0.132, p =
0.006). A median split was made on the number of gen-
eral practitioner consultations, with those attending 6 or
more times defined as 'frequent users'. Logistic regression
determined that those depressed as baseline were more
likely to be frequent users (OR = 2.1, 95% CI 1.3–3.4, p =
0.005), even when controlling for age and sex (OR = 2.0,
95% CI 1.2–3.2, p = 0.008). Depression also predicted fre-
quent users when controlling for prior history of ACS (OR
= 2.1, 95% CI 1.3–3.4, p = 0.005). This finding was
repeated for those who completed the HADS-D (OR = 2.7,
95% CI 1.2–5.9, p = 0.017), but the association was
weaker and not statistically significant for the BDI-FS (OR
= 1.7, 95% CI 0.8–3.3, p = 0.131).
Fifty-six per cent of patients reported attending an outpa-
tient cardiac rehabilitation programme. Depression did
not predict cardiac rehabilitation attendance (OR = 0.6,
95% CI 0.4–1.1, p = 0.120), and remained non-significant
when controlling for prior ACS (OR = 0.7, 95% CI 0.4–
1.2, p = 0.148). The HADS-D did not significantly predict
cardiac rehabilitation attendance (OR = 0.7, 95% CI 0.3–
1.9, p = 0.467), but the BDI-FS did (OR = 0.6, 95% CI 0.3–
1.0, p = 0.039), with depressed BDI-FS cases less likely to
attend.
Psychosocial outcomes
Of those patients who were pre-retirement age (aged <65
on index admission, n = 363), 195 (54%) stated that they
had returned to work at one year. For these patients, the
median duration to return to work was 8 (IQR 4–16)
weeks. Depressed patients were less likely to return to
work (OR = 0.4, 95% CI 0.2–0.8, p = 0.015), even when
controlling for prior ACS (OR = 0.5, 95% CI 0.2–0.9, p =
0.025), or when controlling for age and sex (OR = 0.4,
95% CI 0.2–0.7, p = 0.004). Depressed HADS-D cases
were less likely to return to work (OR = 0.2, 95% CI 0.06–
0.6, p = 0.007), but this did not occur for BDI-FS
depressed cases (OR = 0.7, 95% CI 0.3–1.7, p = 0.444).
Patients were asked to rate their own health since the
index hospitalisation. Patients reported feeling better in
the majority of cases (56%), and feeling the same in
almost a third of cases (31%). 'Don't know' was reported
by 3%, while 10% of patients reported feeling worse at
one year. This variable was dichotomised into 'better or
not' to determine predictors of feeling better. Patients who
were depressed at baseline were less likely to feel better
one year later (OR = 0.6, 95% CI 0.3–1.0, p = 0.05), but
this effect became marginal when controlling for prior
ACS (OR = 0.6, 95% CI 0.4–1.04, p = 0.068), or when
controlling for age and sex (OR = 0.6, 95% CI 0.4–1.04, p
= 0.071). While the effect of depression on subjective
health was similar in the subgroups receiving the HADS-
D (OR = 0.5, 95% CI 0.2–1.2, p = 0.114) and BDI-FS (OR
= 0.6, 95% CI 0.3–1.2, p = 0.123), the associations were
not significant.
Patients reported living with a median of 1 (IQR 1–2)
other person, with 23% of patients living alone. Depres-
sion at baseline (OR = 0.8, 95% CI 0.4–1.7, p = 0.555) or
one-year depression (OR = 0.7, 95% CI 0.4–1.3, p =
0.251) was not related to living alone.
Depression status
Baseline depression and response rates for the overall
sample are reported elsewhere [29]. The response rate for
completing a depression scale in the follow-up sample
was 88% (598/681). Patients were more likely to com-
plete a HADS-D (94%) than a BDI-FS (82%) (OR = 3.4,
95% CI 2.0–5.7, p < 0.001). Patients completed either a
HADS-D at both baseline and follow-up (n = 254), or a
BDI-FS at both baseline and follow-up (n = 193).
Median score for the HADS-D at baseline was 4, and this
was not significantly different to median score of 3 at one-
year follow-up (z = 0.259, p = 0.796). For the BDI-FS,
median baseline score was 1, and one-year median score
was 0 (z = 0.141, p = 0.888). However, this disguises a
substantial switch in depression status of a number of
patients (Figure 2). Eight per cent of the sample who wereBMC Health Services Research 2006, 6:9 http://www.biomedcentral.com/1472-6963/6/9
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depressed at baseline were categorised as not depressed at
one year. Conversely, 10% of the sample who were not
depressed at baseline were classified as depressed at one
year. This change in depression status was seen for both
instrument subgroups. For the HADS-D, 15% of this sub-
sample not depressed at baseline became depressed at one
year, whereas 7% of the BDI-FS subgroup who were not
depressed at baseline became depressed at one year. Seven
per cent of patients were depressed at both baseline and
follow-up. Those depressed at baseline were more likely
to be depressed at one year (OR = 6.6, 95% CI 3.7–11.8,
p < 0.001). Controlling for baseline depression, age (OR
= 0.97 for 1 year increase, 95% CI 0.94–0.996, p = 0.025)
was a significant predictor of one-year depression, but sex
(OR = 1.1, 95% CI 0.6–2.2, p = 0.734), and prior ACS (OR
= 1.5, 95% CI 0.8–2.7, p = 0.186) were not. Participants
with a discharge diagnosis of confirmed acute myocardial
infarction (vs. unstable angina) were less likely to be
depressed at one year (OR = 0.5, 95% CI 0.3–0.9, p =
0.014), when controlling for baseline depression.
Post-hoc scale comparison
Although both scales predicted different outcomes, the
ORs were sometimes very similar. Therefore, in order to
establish whether scales were performing differently to
each other (as opposed to performing differently to
chance alone), Wald post-hoc tests were conducted. The
scales did not differ from each other on predicting taking
anti-depressant, anxiolytic or sleeping medications (p >
0.05 for each), continuation of smoking (p = 0.287), fre-
quent visits to general practitioners (p = 0.188), cardiac
rehabilitation attendance (p = 0.516), feeling better (p =
0.457), or being depressed (p = 0.353) at one year. How-
ever, the HADS-D was significantly different to the BDI-FS
when predicting return to work (p = 0.026).
Discussion
This survey outlines the one-year secondary prevention
profile of ACS patients in Ireland, and the impact of
briefly-assessed depression on this profile. Baseline
depression, as assessed by short-form depression scales,
predicted secondary prevention and psychosocial out-
comes. Results are discussed in terms of secondary preven-
tion, psychosocial outcomes, the impact of depression,
comparison of depression assessment scales, implications
for research and practice, and study limitations.
Secondary prevention profile and psychosocial outcomes
The proportions of patients taking anti-platelet (87%)
and lipid-lowering (84%) therapy at one year compares
favourably to previous research [4-7]. A reported signifi-
cant decrease in 'blood pressure' medications was puz-
zling – it may indicate that patients do not classify the
medications they are taking as being antihypertensive
medications; they may be otherwise classified e.g. 'water
tablets'. Since proportions taking both aspirin and lipid-
lowering medications did not change, there is little evi-
dence to suggest that an overall reduction in adherence to
secondary prevention medication was seen in the sample.
The prevalence of smoking (22%) one year post-ACS is in
line with other research [6,7]. Cardiac rehabilitation
attendance was reported by 56% of the sample. Given the
propensity for cardiac rehabilitation to reduce clinical
morbidity and mortality [3], this finding is a cause for
concern. The majority of eligible patients reported return-
ing to work after a median of eight weeks, while over half
(56%) of patients reported feeling better one year after the
ACS event. Overall, the secondary prevention profile of
the sample was comparable with other research [4-7], and
these results should therefore have good generalisability.
Impact of depression
Previous research found that depressed patients reported
taking cardiovascular medications less often than those
without depression [13]. In contrast, depressed patients in
the current study were not less likely to report taking car-
diovascular medications. Although depressed patients in
the current study reported still taking these medications at
one year, it is unknown if these patients take them less
often than recommended. Depressed patients were more
likely to be taking antidepressant, anxiolytic and sleep
medications at one year – this provides a form of valida-
tion for the short-form depression scales.
Baseline depression predicted continuation of smoking,
as has been found in other research [15]. Smoking cessa-
tion strategies may thus need to incorporate some aspect
of depression measurement and treatment in those
patients who find it difficult to stop smoking.
An increased number of general practitioner visits were
made by depressed patients, and depressed patients were
also less likely to return to work. These findings remained
even when controlling for age and sex, and are consistent
with previous research [16,19]. These results represent fur-
ther costs of depression for patients, employers and health
providers, and support other research which has found
that depressed patients are an increased burden on health-
care resources both in terms of usage and cost [14,16,19].
Baseline depressed cases were less likely to feel better, but
this relationship became marginal when controlling for
gender (supporting a hypothesis of worse psychosocial
outcomes for women post-ACS – data not shown). Over-
all, these results imply that not only do depressed patients
have worse outcomes in terms of mortality (hazard ratio
= 2.8 for one-year mortality [29]) and health service use,
but that the surviving depressed patients also perceive
their general health outcomes to be worse. These effectsBMC Health Services Research 2006, 6:9 http://www.biomedcentral.com/1472-6963/6/9
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were maintained when controlling for a proxy of severity
of ACS (i.e. length of hospital stay – data not shown),
showing the robust nature of these findings, and high-
lighting the importance of treating depression in this pop-
ulation.
Importantly, a prior history of ACS had little impact on
secondary prevention outcomes in the current sample.
This indicates that the depression scales were robust in
predicting outcomes, regardless of previous cardiovascu-
lar history.
Seven per cent of patients were depressed at both baseline
and follow-up. It is not known from the data whether
these patients fluctuated between depression or no
depression, or whether they were consistently depressed
throughout the year post-event. Fluctuations in depressive
status are not uncommon in research with hospital
patients [20,30-32]. It was also possible that the patients
in the current sample were depressed prior to the acute
episode. Previous research has shown that those with
more severe depression, and a history of depression, have
worse outcomes [33,34]. Also of note in the current sam-
ple was that younger patients were more likely to be
depressed at one year, but women were not. That younger
patients were more likely to be depressed supports previ-
ous findings [22,32], but the absence of a relationship
between depression and sex contradicts previous research
[16]. Sex was not related to baseline depression (data not
shown). It may be that in the present survey women did
not find the acute cardiac event any more stressful than
men, therefore this relationship remained non-significant
at one year.
Those discharged with confirmed myocardial infarction
(vs. unstable angina) were less likely to be depressed at
one year. This is surprising, given that myocardial infarc-
tion would be considered a more stressful event. How-
ever, previous research has found a higher prevalence of
depression in personss with unstable angina than in those
with myocardial infarction [10,11]. It may be that fre-
quent episodes of recurrent angina contribute to higher
rates of stress and subsequent depression. An alternative
hypothesis is that depressed patients have more chest pain
as part of the somatisation of their depression.
A number of mechanisms have been postulated over time
to explain the relationship between cardiovascular disease
and depression [35], but coverage is beyond the scope of
this paper. However, more recently some researchers have
postulated that depression may simply be a marker of dis-
ease severity [36]. The finding in the present study that
'depressed' patients were more frequent visitors to general
practitioners may provide some support for this hypothe-
sis. Alternatively, it may be that depressed patients have
other ailments which require more frequent visits or that
depression  per se induces professional help-seeking
behaviour. The data in the present study cannot clarify
this point further.
Further research should concentrate on documenting the
natural history of depression after an acute event, to give
an accurate picture of the progress of depressive symp-
toms over the course of one year, and provide data on
how fluctuating depressive symptoms impact on morbid-
ity, mortality, service use and psychosocial outcomes.
Scale comparison
Two depression scales were independently assessed in this
survey. The baseline HADS-D predicted return to work
and increased general practitioner visits. The BDI-FS pre-
dicted continuation of smoking at one year and cardiac
rehabilitation attendance (although combined depres-
sion scores did not predict cardiac rehabilitation attend-
ance). Neither scale independently predicted perceived
health ratings at one year. When the data was combined,
having depression at baseline predicted not feeling better
at one year, indicating a small effect size which neither
scale was sensitive enough to detect with a split sample.
Post-hoc comparisons of the scales showed no significant
differences between them, except when predicting return
to work, where the HADS-D was superior. Since the
HADS-D predicted one-year mortality [29], it could be
that the more predictive or stable HADS-D depressed
cases were thus eliminated from the current analysis. The
BDI-FS did not predict mortality, and this could have left
the more stable or predictive depressed cases to be
included in the BDI-FS sub-sample. Response rates at one
year showed that patients were more likely to complete a
HADS-D than a BDI-FS, possibly indicating that questions
on the BDI-FS scale were considered more intrusive by
patients. Considering these results, we recommend that
the HADS-D be incorporated into everyday coronary care
practice, as it can predict useful psychosocial and health
service outcomes in ACS patients and is acceptable to
patients.
Change in depressive status between baseline and one year Figure 2
Change in depressive status between baseline and one year.BMC Health Services Research 2006, 6:9 http://www.biomedcentral.com/1472-6963/6/9
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Implications for research and practice
The results of the present survey show the importance and
clinical utility of measuring depression with short-form
depression scales. Baseline depression was predictive of
outcomes in a group of patients with a relatively good sec-
ondary prevention profile, and routine assessment would
identify those at increased risk of poorer outcomes. Over-
all, these findings indicate that short-form depression
questionnaires are an acceptable substitute for clinical
interviews in a setting where depression would not be rou-
tinely assessed, and would provide evidence that a patient
may require more thorough assessment. This is an impor-
tant finding for health services research, as it shows that
complex methodologies can be replicated in a more sim-
plified manner, with less pressure on patients, service pro-
viders and researchers. Obviously, clinical interviews and
longer questionnaires provide superior quality data, but
these options are not feasible in all acute settings for either
the health provider or the patients.
Identification of depressed patients is advisable for both
service providers and patients. The prevalence of depres-
sion and the poorer outcomes seen in this group provide
support for the treatment of depression to enhance
patients' quality of life, and to reduce the costs to service
providers through reducing the negative outcomes associ-
ated with depression. The use of brief scales may be a first
step towards tackling this problem in patients with ACS.
Study limitations
This study has several limitations. The power of the study
was restricted by the eventual sample size at follow-up,
and by the reduced numbers who completed a depression
scale at baseline. This was evidenced by wide confidence
intervals when predicting outcomes, and results must be
interpreted with caution. The effects of selection bias must
be considered given that respondents were more likely to
have private insurance and less likely to have diabetes or
be depressed at baseline. It may be that the full impact of
depression is not being assessed in the present study, due
to depressed patients being less likely to respond at one
year. Depression may therefore have an even greater
impact than that shown in this study.
There is also the potential for unmeasured confounding in
the results. For example, it may be that the persons indi-
cated as depressed may have had a more sedentary life-
style. This may then have influenced outcomes such as
cardiac rehabilitation attendance, return to work, or not
feeling better. The interaction of depression and other
outcomes may be more complex than these results sug-
gest.
Since the present study was based in one country, results
may not be generalisable to other countries for two rea-
sons. Firstly, the secondary prevention profile compares
favourably to that in other European countries [4-7]. Sec-
ondly, depressive symptoms may be experienced differ-
ently in different cultures/countries. However, at least two
large studies [37,38] have shown that the impact of
depression on physical health is similar across popula-
tions and countries. Thus there is some evidence support-
ive of cross-cultural generalisability.
Conclusion
Rapid depression assessment can be used in health serv-
ices research to help identify those at risk of a range of
poorer secondary prevention outcomes. The results pro-
vide support for the routine screening of depression in
acute cardiac patients. Strategies to increase smoking ces-
sation, return to work, general well-being and decrease
health service use by depressed patients may need to
incorporate some element of depression treatment.
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